4483N Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Multi-year Revenue ExpansionSustained multi-year revenue expansion and solid profitability imply the company’s products and data services have ongoing demand from life sciences and insurers. This durable top-line growth supports reinvestment, scale benefits, and predictable enterprise sales over a 2–6 month horizon and beyond.
Data-driven Recurring Business ModelA core business of monetizing curated healthcare data with recurring fees and analytics services creates sticky, contract-based revenue. Enterprise use by pharma and insurers raises switching costs and supports predictable renewals, making revenue more durable versus one-off offerings.
Positive Recent Free Cash Flow And MarginsPositive recent free cash flow that tracks earnings, combined with healthy gross and operating margins, indicates quality earnings and internal funding capacity. Sustainable cash generation supports R&D, data acquisition, and platform investments without immediate external financing.
Bears Say
Rising Leverage Versus Earlier YearsAn increasing leverage profile reduces financial flexibility and raises refinancing risk if growth slows. Higher debt loads can constrain capital allocation, force tighter cash management, and amplify downside during adverse industry or reimbursement shifts over the medium term.
Volatile Cash-flow ConversionInconsistent conversion of earnings to free cash flow, including a weak/negative year, increases uncertainty around funding for investments and dividends. Persistent lumpiness from working-capital swings undermines planning and reduces the predictability of available cash for strategic initiatives.
Moderating Growth And Margin DriftSlowing top-line growth combined with downward pressure on net margins suggests challenges in scaling or rising costs. If mix, investment, or pricing dynamics continue, earnings expansion may slow, lowering return-on-capital trends and making long-term margin recovery more difficult.
4483N FAQ
What was JMDC Inc.’s price range in the past 12 months?
Currently, no data Available
What is JMDC Inc.’s market cap?
JMDC Inc.’s market cap is $25.86B.
When is JMDC Inc.’s upcoming earnings report date?
JMDC Inc.’s upcoming earnings report date is Oct 30, 2026 which is in 50 days.
How were JMDC Inc.’s earnings last quarter?
JMDC Inc. released its earnings results on Aug 05, 2026. The company reported $1.849 earnings per share for the quarter, beating the consensus estimate of $0.972 by $0.878.
Is JMDC Inc. overvalued?
According to Wall Street analysts JMDC Inc.’s price is currently Undervalued.
Does JMDC Inc. pay dividends?
JMDC Inc. does not currently pay dividends.
What is JMDC Inc.’s EPS estimate?
JMDC Inc.’s EPS estimate is 2.82.
How many shares outstanding does JMDC Inc. have?
JMDC Inc. has 65,446,205 shares outstanding.
What happened to JMDC Inc.’s price movement after its last earnings report?
JMDC Inc. reported an EPS of $1.849 in its last earnings report, beating expectations of $0.972. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of JMDC Inc.?
Currently, no hedge funds are holding shares in MX:4483N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
JMDC Inc.
JMDC Inc. is a Japanese corporation primarily focused on delivering analytical and statistical services for the medical sector. Its operations are structured across three principal divisions: Healthcare-Big Data, Telemedicine, and Dispensing Pharmacy Support. Within the Healthcare-Big Data segment, the company provides extensive big data solutions tailored for both the medical and life insurance industries. It also offers crucial support services to health insurance associations and local government health programs, develops a robust health data platform, and aids medical institutions. The Telemedicine division facilitates remote medical imaging interpretation through specialized matching services and ASP systems. Concurrently, its Dispensing Pharmacy Support segment develops and markets bespoke business management software specifically designed for dispensing pharmacies. JMDC serves a broad spectrum of clients, including health insurance providers, pharmaceutical manufacturers, life and general insurance companies, and research organizations. The company, established in 2002, maintains its corporate headquarters in Tokyo, Japan.
4483N Stock 12 Month Forecast
Average Price Target
$481.36